001     288855
005     20250528140039.0
024 7 _ |a 10.1016/j.jhep.2024.02.029
|2 doi
024 7 _ |a pmid:38460792
|2 pmid
024 7 _ |a 0168-8278
|2 ISSN
024 7 _ |a 1600-0641
|2 ISSN
024 7 _ |a altmetric:160607846
|2 altmetric
037 _ _ |a DKFZ-2024-00502
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Seitz, Stefan
|0 P:(DE-He78)ceac1da6bb3c2176c2be7ef93a1e54cc
|b 0
|e First author
|u dkfz
245 _ _ |a Cutting edges in the hepatitis B virus genome: How RNA splicing is involved in modulating virus ultrastructure to promote infection.
260 _ _ |a [Erscheinungsort nicht ermittelbar]
|c 2024
|b Wiley-Blackwell
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1716294359_2021
|2 PUB:(DE-HGF)
|x Editorial
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:F170#LA:F170# / 2024 Jun;80(6):832-833 /NEU/ #EA:D430#LA:D430#
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Bartenschlager, Ralf
|0 P:(DE-He78)1d3968d2f0ff3eae55f6b2ea4c474387
|b 1
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.jhep.2024.02.029
|g p. S016882782400148X
|0 PERI:(DE-600)2027112-8
|n 6
|p 832-833
|t Journal of hepatology
|v 80
|y 2024
|x 0168-8278
856 4 _ |u https://inrepo02.dkfz.de/record/288855/files/1-s2.0-S016882782400148X-main-1.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/288855/files/1-s2.0-S016882782400148X-main-1.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:inrepo02.dkfz.de:288855
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)ceac1da6bb3c2176c2be7ef93a1e54cc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)1d3968d2f0ff3eae55f6b2ea4c474387
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2024
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-24
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-24
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-24
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J HEPATOL : 2022
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-24
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-24
915 _ _ |a IF >= 25
|0 StatID:(DE-HGF)9925
|2 StatID
|b J HEPATOL : 2022
|d 2023-10-24
920 2 _ |0 I:(DE-He78)F170-20160331
|k F170
|l Virus-assoziierte Karzinogenese
|x 0
920 1 _ |0 I:(DE-He78)F170-20160331
|k F170
|l Virus-assoziierte Karzinogenese
|x 0
920 1 _ |0 I:(DE-He78)D430-20160331
|k D430
|l Virus-assoziierte Karzinogenese
|x 1
920 0 _ |0 I:(DE-He78)F170-20160331
|k F170
|l Virus-assoziierte Karzinogenese
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F170-20160331
980 _ _ |a I:(DE-He78)D430-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21